Mutant KRAS and p53 proteinsare associated with the release of EVs and can be identified in SiEVs,allowing for the detection of stage 1 pancreatic cancer. Furthermore, the examination of multiple EVssimultaneously improves the accuracy of diagnosis for PDAC. This evidence concerns the gene TP53 and pancreatic neoplasm.